Company: HBCYF
Filing Date: 2025-03-19
Form Type: 6-K
Source: 0001654954-25-003004
Chunk: 0

Company: HSBC HOLDINGS PLC
Filing Date: 2025-03-19
Form: 6-K
Chunk 0
---
#### FORM 6-K

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

#### Report of Foreign Private Issuer

#### Pursuant to Rule 13a - 16 or 15d - 16 of

#### the Securities Exchange Act of 1934
<div align='center'>For the month of March</div>

#### HSBC Holdings plc
<div align='center'>42nd Floor, 8 Canada Square, London E14 5HQ, England

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F).

Form 20-F X Form 40-F</div>

On 19 March 2025, HSBC submitted the below announcement to the Stock Exchange of Hong Kong Limited regarding a waiver from strict compliance with the requirements of Rule 13.36(1) of the Hong Kong Listing Rules relating to contingent convertible securities.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document.

| 19         
 March 2025 | -Hong              
 Kong Stock Code: 5 |

### HSBC HOLDINGS PLC
<div align='center'>**Waiver granted pursuant to Rule 13.36(1) of the Hong Kong Listing Rules relating to contingent convertible securities**</div>

HSBC Holdings plc (the " Company ") has applied for, and The Stock Exchange of Hong Kong Limited has granted, a waiver from strict compliance with the requirements of Rule 13.36(1) of The Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the " Hong Kong Listing Rules ") pursuant to which the Company is permitted to seek (and, if approved, to utilise) an authority (the " Mandate ") to issue Contingent Convertible Securities (" CCSs ") (and to allot ordinary shares into which they may be converted or exchanged) in excess of the limit of the general mandate of 20 per cent of the Company's issued share capital (the " Waiver ").

CCSs are debt securities which convert into ordinary shares in certain prescribed circumstances, and which benefit from a particular regulatory capital treatment under European Union and United Kingdom legislation.

The Company typically seeks at each annual general